JP2016506736A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016506736A5 JP2016506736A5 JP2015556262A JP2015556262A JP2016506736A5 JP 2016506736 A5 JP2016506736 A5 JP 2016506736A5 JP 2015556262 A JP2015556262 A JP 2015556262A JP 2015556262 A JP2015556262 A JP 2015556262A JP 2016506736 A5 JP2016506736 A5 JP 2016506736A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- heregulin
- cells
- chga
- kinase inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/761,078 | 2013-02-06 | ||
| US13/761,078 US9109245B2 (en) | 2009-04-22 | 2013-02-06 | Cell compositions derived from dedifferentiated reprogrammed cells |
| PCT/US2014/015156 WO2014124172A1 (en) | 2013-02-06 | 2014-02-06 | Cell compositions derived from dedifferentiated reprogrammed cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019078983A Division JP6721752B2 (ja) | 2013-02-06 | 2019-04-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016506736A JP2016506736A (ja) | 2016-03-07 |
| JP2016506736A5 true JP2016506736A5 (enExample) | 2017-03-09 |
| JP6517702B2 JP6517702B2 (ja) | 2019-05-22 |
Family
ID=50239931
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015556262A Active JP6517702B2 (ja) | 2013-02-06 | 2014-02-06 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2019078983A Active JP6721752B2 (ja) | 2013-02-06 | 2019-04-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2020104982A Active JP7250731B2 (ja) | 2013-02-06 | 2020-06-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2022172222A Active JP7550830B2 (ja) | 2013-02-06 | 2022-10-27 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2024151116A Pending JP2025000625A (ja) | 2013-02-06 | 2024-09-03 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019078983A Active JP6721752B2 (ja) | 2013-02-06 | 2019-04-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2020104982A Active JP7250731B2 (ja) | 2013-02-06 | 2020-06-18 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2022172222A Active JP7550830B2 (ja) | 2013-02-06 | 2022-10-27 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
| JP2024151116A Pending JP2025000625A (ja) | 2013-02-06 | 2024-09-03 | 脱分化したリプログラミングされた細胞から導出された細胞組成物 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2954045A1 (enExample) |
| JP (5) | JP6517702B2 (enExample) |
| AU (5) | AU2014214879A1 (enExample) |
| CA (2) | CA2898431C (enExample) |
| HK (1) | HK1218139A1 (enExample) |
| IL (6) | IL321825A (enExample) |
| RU (2) | RU2754089C2 (enExample) |
| WO (1) | WO2014124172A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
| SG11201700874SA (en) | 2014-08-04 | 2017-03-30 | Takeda Pharmaceuticals Co | Method for proliferation of pancreatic progenitor cells |
| WO2017180361A1 (en) * | 2016-04-14 | 2017-10-19 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells to intestinal midgut endoderm cells |
| EP3690022B1 (en) * | 2016-05-18 | 2026-03-18 | Keio University | Cell culture medium for culturing organoid, culture method, and organoid |
| KR102448428B1 (ko) | 2017-01-27 | 2022-09-30 | 가부시키가이샤 가네카 | 내배엽계 세포 집단, 및 다능성 세포로부터 3배엽 중 어느 하나의 세포 집단을 제조하는 방법 |
| IL313825B2 (en) | 2017-06-14 | 2025-07-01 | Vertex Pharma | Devices and methods for administering medications |
| JP2020527956A (ja) * | 2017-07-21 | 2020-09-17 | センマ・セラピューティクス・インコーポレーテッド | 幹細胞由来の膵臓ベータ細胞の再凝集 |
| WO2019169351A1 (en) | 2018-03-02 | 2019-09-06 | Semma Therapeutics, Inc. | Methods of enhancing stem cell differentiation into beta cells |
| CN112912490B (zh) * | 2018-08-03 | 2023-12-26 | 千纸鹤治疗公司 | 细胞制造方法 |
| TWI862513B (zh) * | 2018-09-19 | 2024-11-21 | 日商千紙鶴治療公司 | 包含胰島素產生細胞之細胞集團、包含該細胞集團之醫藥、其用途及製造方法 |
| AU2020282355B2 (en) | 2019-05-31 | 2023-11-02 | Viacyte, Inc. | A biocompatible membrane composite |
| US12310830B2 (en) | 2019-05-31 | 2025-05-27 | W. L. Gore & Associates, Inc. | Biocompatible membrane composite |
| CA3257300A1 (en) | 2019-05-31 | 2025-06-12 | W. L. Gore & Associates, Inc. | Cell encapsulation devices with controlled oxygen diffusion distances |
| EP3975926A1 (en) | 2019-05-31 | 2022-04-06 | W.L. Gore & Associates, Inc. | A biocompatible membrane composite |
| JP7705448B2 (ja) | 2020-07-31 | 2025-07-09 | バーテックス ファーマシューティカルズ インコーポレイテッド | 膵内分泌細胞の分化 |
| EP4596675A4 (en) * | 2022-09-26 | 2026-03-11 | Univ Kyoto | PROCESS FOR THE PRODUCTION OF PANCREATIC ENDODERMAL CELLS |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4794049B2 (ja) * | 1999-04-06 | 2011-10-12 | ジェネンテック， インコーポレイテッド | 糖尿病治療へのＥｒｂＢレセプターリガンドの使用 |
| US6759039B2 (en) * | 2000-06-30 | 2004-07-06 | Amcyte, Inc. | Culturing pancreatic stem cells having a specified, intermediate stage of development |
| CA2435826A1 (en) * | 2001-01-24 | 2002-08-01 | The Government Of The United States Of America | Differentiation of stem cells to pancreatic endocrine cells |
| CA2625883A1 (en) * | 2005-10-14 | 2007-04-26 | Regents Of The University Of Minnesota | Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype |
| US20090298169A1 (en) * | 2006-06-02 | 2009-12-03 | The University Of Georgia Research Foundation | Pancreatic and Liver Endoderm Cells and Tissue by Differentiation of Definitive Endoderm Cells Obtained from Human Embryonic Stems |
| EP2356227B1 (en) | 2008-11-14 | 2018-03-28 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
| ES2849181T3 (es) * | 2009-04-22 | 2021-08-16 | Viacyte Inc | Composiciones celulares derivadas de células reprogramadas desdiferenciadas |
| US9109245B2 (en) * | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
| WO2010129294A2 (en) * | 2009-04-27 | 2010-11-11 | Schulz Thomas C | Small molecules supporting pluripotent cell growth and methods thereof |
| EP2436397B1 (en) * | 2009-05-29 | 2017-05-10 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition containing antagonist of egf family ligand as component |
-
2014
- 2014-02-06 IL IL321825A patent/IL321825A/en unknown
- 2014-02-06 CA CA2898431A patent/CA2898431C/en active Active
- 2014-02-06 RU RU2018144412A patent/RU2754089C2/ru active
- 2014-02-06 JP JP2015556262A patent/JP6517702B2/ja active Active
- 2014-02-06 EP EP14708981.7A patent/EP2954045A1/en active Pending
- 2014-02-06 AU AU2014214879A patent/AU2014214879A1/en not_active Abandoned
- 2014-02-06 HK HK16106057.9A patent/HK1218139A1/zh unknown
- 2014-02-06 WO PCT/US2014/015156 patent/WO2014124172A1/en not_active Ceased
- 2014-02-06 RU RU2015131279A patent/RU2675928C2/ru active
- 2014-02-06 CA CA3212301A patent/CA3212301A1/en active Pending
- 2014-02-06 IL IL290717A patent/IL290717B2/en unknown
- 2014-02-06 IL IL326919A patent/IL326919A/en unknown
- 2014-02-06 IL IL311689A patent/IL311689B2/en unknown
-
2015
- 2015-07-15 IL IL239953A patent/IL239953B/en active IP Right Grant
-
2019
- 2019-02-26 AU AU2019201314A patent/AU2019201314B2/en active Active
- 2019-04-18 JP JP2019078983A patent/JP6721752B2/ja active Active
-
2020
- 2020-06-18 JP JP2020104982A patent/JP7250731B2/ja active Active
-
2021
- 2021-05-10 IL IL283088A patent/IL283088B/en unknown
-
2022
- 2022-01-07 AU AU2022200075A patent/AU2022200075C1/en active Active
- 2022-10-27 JP JP2022172222A patent/JP7550830B2/ja active Active
-
2023
- 2023-04-26 AU AU2023202507A patent/AU2023202507B2/en active Active
-
2024
- 2024-09-03 JP JP2024151116A patent/JP2025000625A/ja active Pending
-
2026
- 2026-03-02 AU AU2026201562A patent/AU2026201562A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015131279A (ru) | Композиции клеток, полученные из дедифференцированных перепрограммированных клеток | |
| Kennedy et al. | Production of functional small interfering RNAs by an amino-terminal deletion mutant of human Dicer | |
| ZA202003137B (en) | Nucleic acid, composition and conjugate containing same, and preparation method and use | |
| Comes et al. | L-Proline induces a mesenchymal-like invasive program in embryonic stem cells by remodeling H3K9 and H3K36 methylation | |
| Waghray et al. | Tbx3 controls Dppa3 levels and exit from pluripotency toward mesoderm | |
| Bagci et al. | DNA demethylation in pluripotency and reprogramming: the role of tet proteins and cell division | |
| Diallo et al. | A tRNA-derived fragment present in E. coli OMVs regulates host cell gene expression and proliferation | |
| JP2016513972A5 (enExample) | ||
| NZ607608A (en) | Method of producing pancreatic hormone-producing cells | |
| SG11201809201UA (en) | Method for producing retinal tissue | |
| WO2012034101A3 (en) | Expandable cell source of neuronal stem cell populations and methods for obtaining and using them | |
| JP2016521971A5 (enExample) | ||
| EP4427809A3 (en) | Altering gene expression in car-t cells and uses thereof | |
| JP2017515507A5 (enExample) | ||
| WO2010008486A3 (en) | Pluripotent cell lines and methods of use thereof | |
| MY191740A (en) | Production method for nerve tissue | |
| WO2012021632A3 (en) | Generation and use of pluripotent stem cells | |
| BR112015019950A2 (pt) | Método para gerar linhagem de células-tronco embrionárias (es) de rato, e, cultura in vitro | |
| MY183058A (en) | Production method for retinal tissue | |
| WO2015120096A3 (en) | Methods for producing autologous t cells useful to treat b cell malignancies and other cancers and compositions thereof | |
| CY1122993T1 (el) | Μεθοδος παραγωγης για πολυδυναμα βλαστοκυτταρα που εχουν αντιγονο-ειδικο γονιδιο υποδοχεα τ κυτταρων | |
| WO2016007570A3 (en) | Engineered invariant natural killer t (inkt) cells and methods of making and using thereof | |
| WO2016055519A1 (en) | Endogenous retrovirus transcription as a marker for primate naïve pluripotent stem cells | |
| Rawte et al. | A rapid hypochlorite method for extraction of polyhydroxy alkanoates from bacterial cells. | |
| WO2019140116A3 (en) | Amplifiable rnas for therapeutic cell systems |